U7D-1 - Moligand™, 10 mM in DMSO

Cat. No.: U1497469
Zu bestellen verfügbar
QUALITÄT & REINHEIT Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. 10 mM in DMSO
Storage
Store at -80°C
Shipped In
Dry ice packs + Cold packs
★
Größe
Deutschland (EU)
USA*
Preis
Menge
1ml
U1497469-1ml
Auf Bestellung · 8–12 Wochen
2.073,81€
Enter a quantity for the sizes you want to add.

Übersicht

U7D-1 is a first-in-class potent and selective USP7 ( ubiquitin-specific protease 7 ) PROTAC degrader, with a DC 50 of 33 nM in RS4;11 cells. U7D-1 shows anticancer activity. U7D-1 induces apoptosis in Jeko-1 cells.

Spezifikationen

Spezifikationen & Reinheit
Moligand™, 10 mM in DMSO
Storage
Store at -80°C
Verschickt in
Dry ice packs + Cold packs
Dieses Produkt erfordert Kühlkettenversand. Grundversand und andere Economy-Optionen sind nicht verfügbar.
Note
Moligand™

Erweiterte Daten

Zertifikate (CoA, COO, BSE/TSE und Analyse-Diagramm)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Lösungsrechner
Bewertungen

Kundenbewertungen

Application Protocols

No item-specific, validated protocols are provided for U7D-1. The following general workflow reflects common practice for screening compounds and should be adapted to your assay format and internal SOPs.

General HTS/assay handling (guidance):

  • Receipt and storage: Verify package integrity upon arrival (shipped on dry ice + cold packs, product-specific). Transfer immediately to −80°C storage (product-specific). Document lot and date.
  • Aliquoting: If supplied as solid, pre-dry atmosphere and weigh quickly. If supplied as solution, prepare single-use aliquots to avoid repeated freeze–thaw.
  • Stock preparation: Dissolve in an appropriate solvent (commonly DMSO) to a convenient concentration (e.g., 10–50 mM; general guidance only). Mix gently; sonicate briefly if needed. Record exact solvent and concentration.
  • Assay setup: Dilute stocks into buffer/media to target concentrations, maintaining consistent final solvent % across controls and treated samples. Include vehicle controls and, when relevant, positive/negative controls.
  • Plate handling: Use low-binding plates or surfactant-free conditions as required by the assay. Seal plates to limit evaporation; equilibrate to assay temperature before reading.
  • Data quality: Include replicates and appropriate counterscreens to identify interference. Confirm hits with fresh aliquots and independent methods.

Please consult the CoA/Spec Sheet and SDS for any item-specific instructions, and validate the above steps within your laboratory’s QA framework.

Biological Roles

No biological role, target, pathway association, or mechanism-of-action information is provided for U7D-1 in the Product Data.

Context for library compounds (general):

  • Library members may be tool-like ligands, fragments, diversity-oriented scaffolds, or annotated chemotypes. Without structure and annotation, we cannot associate U7D-1 with any biological pathway or molecular target.
  • If you plan biochemical or cellular assays, treat U7D-1 as an uncharacterized small molecule and include appropriate controls:
    • Vehicle controls matched to solvent content (e.g., DMSO percentage).
    • Cytotoxicity/cell health counterscreens (e.g., resazurin, ATP content) in cell-based assays.
    • Assay interference checks for fluorescence/absorbance overlap or redox reactivity where relevant.

Data capture guidance (general):

  • Record exact lot, concentration, solvent, and assay conditions; retain raw spectral/plate data to facilitate hit triage.
  • For any observed activity, pursue orthogonal confirmation (e.g., biophysical binding or alternate readout) to exclude false positives.

Important: Aladdin Scientific supplies U7D-1 for research use only. No medical, diagnostic, or therapeutic claims are implied or permitted. For target specificity or annotated biology, consult the CoA/Spec Sheet or contact Support with your data needs.

Buffer Applications

Buffering is not typically applicable to an undefined small-molecule library member. U7D-1 is not a buffering reagent, and the Product Data provide no pKa or acid/base properties from which to design a buffer system.

Practical notes for assay buffers (general guidance):

  • Choose a buffer appropriate to your assay target (e.g., HEPES, PBS, Tris) and maintain consistent ionic strength. Keep the final organic co-solvent (e.g., DMSO) constant across controls and treatments.
  • If U7D-1 is dissolved in DMSO for a concentrated stock, pre-equilibrate buffer to assay temperature before dilution to minimize precipitation. Mix gently and inspect for haze or particulates.
  • If pH-dependent solubility is suspected, perform a small solubility screen across your working pH range using identical ionic strength and additives.

Since no ionization data or buffer roles are specified for U7D-1, defer to your assay’s established buffer system and verify compound compatibility empirically.

Green Alternatives

With no structure or solvent requirements specified for U7D-1, green chemistry considerations focus on solvent choice and waste minimization during assay preparation. The following are general recommendations to reduce environmental footprint while maintaining data quality.

  • Reduce DMSO load: While DMSO is widely used for stocks, keep final assay DMSO at the lowest validated level (often 0.1–0.5%) compatible with solubility and biology. This reduces cytotoxicity and solvent waste.
  • Prefer aqueous buffers: Where compound solubility permits, favor direct dissolution in buffered aqueous systems with minimal co-solvent. Validate stability and activity to avoid confounding precipitation.
  • Alternative solvents (general comparison):

| Solvent | Greener aspect | Trade-offs | |---|---|---| | Water (buffered) | Benign; minimal VOCs | Limited solvency for hydrophobic molecules | | Ethanol/IPA | Bio-based availability; lower toxicity than DMF | Lower solvency vs DMSO; volatility | | 2-MeTHF | Bio-derived, greener than THF for synthesis contexts | Rarely used in bioassays; immiscible with water | | PEG-400 cosolvent (low %) | Low volatility | Viscosity; assay interference potential |

  • Minimize waste: Use micro-aliquots to limit freeze–thaw and discarded residues; adopt 384/1536-well formats when feasible to reduce reagent consumption.
  • Energy considerations: Store at −80°C as required for stability (product-specific), but avoid unnecessary long door-open times and consolidate freezers to improve energy efficiency.

Note: These are general best practices. Item-specific green handling options for U7D-1 depend on its actual solubility and stability, which are not provided here.

Pharmaceutical Uses

No pharmaceutical or excipient roles are provided for U7D-1 in the Product Data. As a Moligand™ screening-grade library compound, it is supplied strictly for research use only.

General context (non-clinical):

  • Screening compounds and tool molecules may be used in early discovery to probe targets or pathways, develop SAR, or benchmark assay performance. They are not manufactured under GMP and are not intended for human or veterinary administration, clinical diagnostics, or compounding.
  • If you plan formulation-like experiments (e.g., solubility enhancement studies, preformulation screening), treat U7D-1 as a research chemical and avoid extrapolation to clinical use. No pharmacopeial monograph or compendial status is indicated.

Documentation and compliance:

  • Research Use Only (product-specific): The listing explicitly restricts use to research settings.
  • No medical or therapeutic claims are made or implied. For any regulatory or translational work, obtain comprehensive analytical documentation and consider separate sourcing of GMP-grade materials where applicable.
Physical Properties

Item-specific physicochemical data have not been provided for U7D-1.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point: Not specified for this item; refer to CoA/Spec Sheet.
  • Boiling point: Not specified for this item; refer to CoA/Spec Sheet.
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • Refractive index: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility profile (water/organic): Not specified for this item; refer to CoA/Spec Sheet.
  • LogP/logD: Not specified for this item; refer to CoA/Spec Sheet.
  • pKa(s): Not specified for this item; refer to CoA/Spec Sheet.
  • UV-Vis characteristics: Not specified for this item; refer to CoA/Spec Sheet.

General guidance for screening compounds (literature/general):

  • Many screening library members are provided either as dry films or DMSO stock solutions. If supplied neat, typical reconstitution solvents are anhydrous DMSO or DMF, optionally followed by dilution into aqueous assay buffer with co-solvent (e.g., 0.1–1% DMSO). This is general guidance and not a specification for U7D-1.
  • Solubility and stability should be empirically confirmed at working concentrations and assay pH/ionic strength. Consider light sensitivity and potential hydrolysis for labile chemotypes (imines, esters, acid chlorides, etc.). Specific liabilities for U7D-1 are unknown from the Product Data.

Important: For validated physical property values and handling recommendations specific to U7D-1, consult the CoA/Spec Sheet.

Quality and Grades
  • Grade/Purity: Moligand™ (product-specific)

What Moligand™ typically denotes (general description of grade):

  • Intended for discovery and screening workflows (e.g., primary HTS, fragment/ligand screening, tool-compound exploration). Emphasis is on identity confirmation and fitness for in vitro research use.
  • Supplied to facilitate rapid assay deployment: commonly aliquoted or packaged to minimize freeze–thaw and contamination risk. Specific fill format for U7D-1 is not specified.
  • QC elements often associated with screening-grade small molecules may include orthogonal identity checks (e.g., LC-MS) and purity assessment suitable for research decisions. Exact analytical methods and acceptance criteria for U7D-1 are not specified; refer to CoA/Spec Sheet.

What this means for your workflow:

  • For biochemical or cell-based assays, Moligand-grade compounds are typically compatible with DMSO-based stock solutions, followed by dilution into assay media. Confirm solubility and absence of colloidal aggregation empirically.
  • For mechanistic, quantitative SAR, or in vivo enabling studies, you may wish to obtain full analytical documentation (CoA/SDS), and, if needed, perform supplemental QC (e.g., HPLC area%, NMR) to your internal specifications.

Non-negotiables for this listing:

  • No item-specific numeric specifications (e.g., purity %, water content, residual solvents, metals, UV cutoff) are provided in the Product Data. For definitive values, consult the CoA/Spec Sheet.
Reaction and Applications

This product is cataloged as a small-molecule library member (Moligand™) intended for research screening rather than as a preparative reagent. No reaction-specific use cases are provided in the Product Data.

  • Synthetic reactions: Not typically applicable. Without structural information, we cannot recommend its use as a reagent or intermediate in named reactions or synthetic sequences.
  • Screening applications (general guidance):
    • Biochemical assays: Target binding or enzyme modulation screens in 96–1536-well formats.
    • Cell-based assays: Phenotypic profiling, pathway modulation, or reporter assays at controlled DMSO percentages.
    • Biophysical methods: If structure and purity are adequate, techniques such as DSF, MST, SPR, or NMR ligand-observe assays may be used to explore interactions; confirm solubility and absence of aggregation.
  • Practical notes:
    • Prepare fresh working dilutions; minimize freeze–thaw of concentrated stocks.
    • Include vehicle controls (matching DMSO %) and, where possible, orthogonal counterscreens to exclude assay interference.

Because no target or mechanism is provided, any specific reaction chemistry or mode-of-action statements would be speculative. For tailored application advice, obtain the structural data and CoA/Spec Sheet for U7D-1 and align with your assay design.

Reaction Conditions

No reaction conditions are specified for U7D-1, and its structure is not disclosed. Therefore, prescriptive reaction conditions are not applicable for this listing.

General notes for assay solution preparation (not synthetic reactions):

  • Stock solutions: Prepare at a convenient concentration in a suitable solvent (commonly DMSO for screening libraries). Filter if particulate is observed and filtration is compatible.
  • Working dilutions: Dilute into assay buffer or media, maintaining a consistent final co-solvent percentage across all wells/samples. Gently mix to avoid foaming or localized supersaturation.
  • Temperature: Equilibrate reagents to assay temperature before mixing to minimize precipitation; some hydrophobic compounds dissolve better with brief sonication at room temperature. Avoid heating unless stability is known.
  • Light sensitivity: If discoloration occurs, protect from light using amber vials/plates.

If you require actual synthetic reaction guidance, please obtain U7D-1’s structure and intended transformation. Without those, any recommendation on catalysts, bases, temperatures, or expected yields would be speculative and is not provided here.

Safety and Handling

Hazard and classification data are not provided in the Product Data for U7D-1.

  • GHS classification: Not specified for this item; refer to SDS.
  • Signal word / H-statements / pictograms: Not specified for this item; refer to SDS.

General laboratory precautions (best practice):

  • Handle in a chemical fume hood and avoid inhalation, ingestion, and skin/eye contact. Wear appropriate PPE: lab coat, safety glasses, and nitrile gloves; upgrade PPE per risk assessment.
  • Unknown hazard profile: Treat as potentially harmful; avoid aerosolization and heating until you have reviewed the SDS.
  • Incompatibilities: Without structure, specific incompatibilities cannot be stated. As a conservative approach, keep away from strong oxidizers/reducers, strong acids/bases, and reactive metals until compatibility is confirmed.
  • Peroxide formation and flammability: Not applicable unless U7D-1 is an ether or volatile solvent (not specified). Do not assume volatility; consult SDS.
  • First aid (overview; defer to SDS): In case of skin contact, wash with soap and water; eye exposure, rinse with water for 15 minutes and seek medical advice; inhalation, move to fresh air; ingestion, seek medical attention.

Storage and transport context:

  • Storage: Store at −80°C (product-specific).
  • Shipping: Shipped on dry ice packs + cold packs (product-specific), indicating temperature-sensitive material. Minimize freeze–thaw cycles and keep tightly closed to prevent moisture uptake.

Always refer to the item’s SDS for authoritative safety information.

Solvent Selection

Item-specific solubility and solvent preferences are not provided. The following guidance reflects common practice for small-molecule library members and should be verified experimentally for U7D-1.

  • Primary stock solvent (general): Anhydrous DMSO is the most common solvent for screening stocks due to broad solvency and assay compatibility at low percentages. DMF can serve as an alternative for recalcitrant compounds; ethanol or isopropanol may be used when aqueous compatibility is important.
  • Aqueous dilution: After preparing a concentrated organic stock (e.g., 10–50 mM in DMSO), dilute into buffer or media to the working concentration, maintaining minimal organic co-solvent (often 0.1–1% v/v in biochemical assays; verify assay tolerance).
  • pH dependence: If U7D-1 is ionizable (unknown), solubility may vary with pH. Consider pre-dissolution in DMSO, then dilution into buffered systems at the desired pH.
  • Light/air sensitivity: Unknown for U7D-1. As a precaution, protect from light and air during solution prep if rapid discoloration or precipitation is observed.

Comparison (general):

  • DMSO: Highest solvency; broad assay compatibility; potential cytotoxicity above ~1–2%.
  • DMF: Strong solvency; higher toxicity; less favored in cells.
  • EtOH/IPA: Moderate solvency; better biocompatibility but limited for very lipophilic compounds.

Important: Confirm clarity after dilution (no precipitation), and consider using co-solvent titrations or surfactants (e.g., 0.01–0.05% nonionic) only if compatible with your assay. Item-specific solvent recommendations for U7D-1 are not specified.

Storage and Reconstitution

Product-specific conditions:

  • Storage temperature: Store at −80°C.
  • Shipping: Dry ice packs + cold packs.

General guidance for reconstitution and handling of small-molecule library compounds (to be adapted to U7D-1 once specifics are known):

  • Format check: Determine whether U7D-1 is supplied as a dry film/solid or as a DMSO solution. Follow any instructions provided on the container label and CoA.
  • Reconstitution solvent: If solid or film, use anhydrous DMSO as the primary solvent unless item-specific guidance indicates otherwise. Alternative solvents include DMF or ethanol, based on solubility and assay compatibility.
  • Concentration: Prepare concentrated stock solutions suitable for your assay (commonly 10–50 mM; general guidance, not a specification). Record lot, solvent, and exact concentration.
  • Aliquoting: Create single-use aliquots to minimize freeze–thaw. Store tightly sealed, preferably under inert gas and desiccation if sensitivity is suspected.
  • Thawing: Thaw aliquots rapidly at ambient temperature or on ice, mix gently, and use promptly. Avoid repeated freeze–thaw.
  • Stability checks: Visually inspect for precipitation or discoloration; confirm concentration by an appropriate analytical method when critical to data integrity.
  • Disposal: Follow institutional chemical waste procedures; segregate halogenated and non-halogenated organic waste as applicable.

Note: Because appearance, solubility, and stability of U7D-1 are not specified, always defer to the item’s CoA/Spec Sheet and SDS for definitive, item-specific instructions.

Structure and Identity

Brief overview: U7D-1 is listed under our small-molecule/compound library category. No structural identifiers are provided for this catalog entry.

  • Chemical name: Not specified for this item; refer to CoA/Spec Sheet.
  • Synonyms: Not specified for this item; refer to CoA/Spec Sheet.
  • CAS: Not specified for this item; refer to CoA/Spec Sheet.
  • PubChem CID: Not specified for this item; refer to CoA/Spec Sheet.
  • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.

Structural features (general guidance):

  • Functional groups, ring systems, stereochemistry, and ionization state are not disclosed in the Product Data. If you require structural details for computational docking, structure-activity analyses, or analytical method development, please request the full CoA/Spec Sheet for U7D-1.
  • As a library member (Moligand grade), U7D-1 is expected to be a discrete, single small-molecule entity intended for screening assays. However, without identifiers, no specific 2D description can be provided.

2D structure (descriptive):

  • Not specified for this item; refer to CoA/Spec Sheet.

Documentation note:

  • For any structure-driven work (NMR assignment, LC-MS method tuning, predicted logP/pKa, or PAINS filtering), please obtain the structure file (SMILES/SDF) from the accompanying documentation or by contacting Aladdin Scientific Support.
Synthetic Utility

U7D-1 is positioned as a screening-grade small molecule (Moligand™), and no structural information is provided to evaluate synthetic transformations. Consequently, synthetic utility cannot be assessed for this item without additional data.

General considerations if structural data become available:

  • Functional group compatibility: Identification of reactive motifs (e.g., halides, boronates, acids/amines, aldehydes) would inform cross-coupling, amidation, or late-stage diversification options.
  • Protecting-group strategy: Presence of nucleophilic/basic/acidic functionalities would dictate orthogonal protection schemes for analog synthesis.
  • Stability liabilities: Hydrolytically labile groups (esters, lactams, imines) or redox-sensitive moieties would influence storage and reaction planning.

If your intent is synthesis rather than screening:

  • Please request the structural identifiers (SMILES, InChIKey) and CoA/Spec Sheet. With those, we can recommend specific transformations, catalysts, and conditions aligned to the scaffold.

Absent such details, we recommend using U7D-1 as supplied for screening and reserving synthetic efforts for confirmed hits once the structure and reactivity profile are documented.

Target Specificity

Target information is not provided for U7D-1 in the Product Data.

  • Validated target(s): Not specified for this item; refer to CoA/Spec Sheet.
  • Mechanism of action: Not specified for this item; refer to CoA/Spec Sheet.
  • Species selectivity or profiling data: Not specified for this item; refer to CoA/Spec Sheet.

Guidance for users:

  • If you observe activity in your assay, follow up with orthogonal tests (e.g., counter-screens against related targets, biophysical binding) to define specificity and exclude assay artifacts.
  • For computational triage, obtain structure files and run similarity searches, PAINS/REOS filters, and model-based predictions to generate hypotheses prior to detailed profiling.

Note: In the absence of annotation, U7D-1 should be treated as an uncharacterized ligand for discovery research only.

Häufig gestellte Fragen

How is this product shipped?
This product ships frozen with dry ice and cold packs. Unpack on arrival and transfer it to the storage condition stated above; handle dry ice with insulated gloves in a ventilated area.
What is Moligand??
Moligand? is one of Aladdin Scientific's premium product lines, formulated for high-purity applications across multiple workflows. Compared to standard grades in the same workflow, Moligand? products typically offer tighter specifications, more rigorous QC, and stronger lot-to-lot consistency.
How should this product be stored?
Store at ?80 °C. Ultra-low temperature storage is required to maintain the specified shelf life.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Benötigen Sie Hilfe bei der Auswahl der Qualität?

Unser Leitfaden zur Qualitätsauswahl behandelt Reinheit, Stabilisatorstatus und Anwendungseignung für alle Varianten in unserem Katalog.

Moligand™ Qualitätsleitfaden ansehen →

Dürfen wir Sie über Rabattaktionen informieren?

Später erinnern

Vielen Dank! Bitte überprüfen Sie Ihren E-Mail-Posteingang, um zu bestätigen.

Hoppla! Benachrichtigungen sind deaktiviert.